β-1,3-Glucan reduces growth ofMycobacterium tuberculosisin macrophage cultures
Open Access
- 1 March 2002
- journal article
- research article
- Published by Oxford University Press (OUP) in FEMS Immunology & Medical Microbiology
- Vol. 33 (1) , 41-45
- https://doi.org/10.1111/j.1574-695x.2002.tb00570.x
Abstract
The effect of β-1,3-d-glucans SSG, from Sclerotinia sclerotiorum, or soluble (sMG) or particulate (pMG) MacroGard® from baker's yeast on growth of Mycobacterium tuberculosis H37Rv in cultures of peritoneal macrophages from BALB/c mice was examined. After 24 h intracellular bacteria from lysed macrophages were cultured and the number of cfu counted. SSG given with challenge, but not 24 h after, reduced the number of M. tuberculosis cfu significantly. pMG, but not sMG, given with challenge had an even stronger inhibitory effect, which was enhanced after serum opsonization of the particles. The effect of serum-treated pMG was abrogated by addition of a monoclonal antibody to CD11b. The results indicate that β-glucans inhibit growth of M. tuberculosis in host cells in vitro, probably due to cellular stimulation and/or competitive inhibition of uptake of bacteria via CR3 (CD11b/18).Keywords
This publication has 21 references indexed in Scilit:
- Protective Effect of β‐Glucan Against Mycobacterium bovis, BCG Infection in BALB/c MiceScandinavian Journal of Immunology, 1998
- Enhancement of murine alveolar macrophage functions by orally administered β-glucanInternational Journal of Immunopharmacology, 1992
- Bacterial infection modulated by glucan: A search for the host defense potentiation mechanismsFolia Microbiologica, 1992
- Isolation and characterization of beta-glucan receptors on human mononuclear phagocytes.The Journal of Experimental Medicine, 1991
- Phagocytosis of leprosy bacilli is mediated by complement receptors CR1 and CR3 on human monocytes and complement component C3 in serum.Journal of Clinical Investigation, 1990
- Antitumor activity of a highly branched (1.RAR.3)-.BETA.-D-glucan, SSG, obtained from Sclerotinia sclerotiorum IFO 9395.Journal of Pharmacobio-Dynamics, 1987
- Structure and antitumor activity of a .BETA.-1,3-glucan isolated from the culture filtrate of Sclerotinia sclerotiorum IFO 9395.CHEMICAL & PHARMACEUTICAL BULLETIN, 1986
- Stimulatory Effect of Immobilized Glycans on Macrophages in VitroScandinavian Journal of Immunology, 1984
- Failure to trigger the oxidative metabolic burst by normal macrophages: possible mechanism for survival of intracellular pathogens.The Journal of Experimental Medicine, 1980
- Increased Resistance to Staphylococcus aureus Infection and Enhancement in Serum Lysozyme Activity by GlucanScience, 1978